These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 1350381)

  • 1. Identification of heregulin, a specific activator of p185erbB2.
    Holmes WE; Sliwkowski MX; Akita RW; Henzel WJ; Lee J; Park JW; Yansura D; Abadi N; Raab H; Lewis GD
    Science; 1992 May; 256(5060):1205-10. PubMed ID: 1350381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
    Plowman GD; Green JM; Culouscou JM; Carlton GW; Rothwell VM; Buckley S
    Nature; 1993 Dec; 366(6454):473-5. PubMed ID: 7902537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
    J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
    J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
    J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
    Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX
    Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins.
    Culouscou JM; Carlton GW; Aruffo A
    J Biol Chem; 1995 May; 270(21):12857-63. PubMed ID: 7759543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L; Eberhard I; Ma Z; Cho C; Serve H; Liu F; Rosen N; Lupu R
    Oncogene; 1996 Apr; 12(8):1679-87. PubMed ID: 8622888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
    Shu HK; Pelley RJ; Kung HJ
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9103-7. PubMed ID: 1979168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.
    Lev S; Yarden Y; Givol D
    Mol Cell Biol; 1990 Nov; 10(11):6064-8. PubMed ID: 1700279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
    Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
    Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.